Responses
Clinical/translational cancer immunotherapy
Original research
Dose escalation phase 1 study of radiotherapy in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 monoclonal antibody ipilimumab in patients with metastatic melanoma
Compose a Response to This Article
Other responses
No responses have been published for this article.